title: Fulvestrant for advanced male breast cancer patients: a case series.
authors: Department of Medical Oncology and Hematology. Electronic address: giovanna.masci@humanitas.it.
authors: G
authors: G
authors: Masci
authors: Department of Medical Oncology and Hematology.
authors: C
authors: C
authors: Gandini
authors: Department of Medical Oncology and Hematology.
authors: M
authors: M
authors: Zuradelli
authors: Department of Medical Oncology and Hematology.
authors: P
authors: P
authors: Pedrazzoli
authors: Department of Medical Oncology and Hematology.
authors: R
authors: R
authors: Torrisi
authors: Department of Radiology, Istituto Clinico Humanitas, Milan, Italy.
authors: F R
authors: FR
authors: Lutman
authors: Department of Medical Oncology and Hematology.
authors: A
authors: A
authors: Santoro
mesh_terms: D018567:Breast Neoplasms, Male / Q000188:drug therapy* / Q000378:metabolism; D004958:Estradiol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077267:Fulvestrant; D006801:Humans; D008297:Male; D008875:Middle Aged; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000097:blood; D011960:Receptors, Estrogen / Q000378:metabolism; D011980:Receptors, Progesterone / Q000378:metabolism; D013629:Tamoxifen / Q000627:therapeutic use; D013739:Testosterone / Q000097:blood
chemical_list: D004958:Estradiol; D000077267:Fulvestrant; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D013629:Tamoxifen; D013739:Testosterone; C508053:ERBB2 protein, human